HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease

Details for Australian Patent Application No. 2003300676 (hide)

Owner AURELIUM BIOPHARMA INC.

Inventors Bonneau, Anne-Marie; Serfass, Lucile; Dallaire, Frederic; Georges, Elias

Agent FB Rice

Pub. Number AU-A-2003300676

PCT Number PCT/IB2003/0064

PCT Pub. Number WO2004/061458

Priority 60/438,012 03.01.03 US

Filing date 15 December 2003

Wipo publication date 29 July 2004

International Classifications

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 60/438,012 03.01.03 US

2 September 2004 Application Open to Public Inspection

  Published as AU-A-2003300676

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003300677-CLEANING COMPUND FOR AND METHOD OF CLEANING VALVES AND ACTUATORS OF METERED DOSE DISPENSERS CONTAINING PHARMACEUTICAL COMPOSITIONS

2003300675-A process for preparing ultra high molecular weight polyethylene fibres